Article
CCDC167 as a potential therapeutic target and regulator of cell cycle-related networks in breast cancer
10 Jan 2021
Abstract excerpt
According to cancer statistics reported in 2020, breast cancer constitutes 30% of new cancer cases diagnosed in American women. Histological markers of breast cancer are expressions of the estrogen receptor (ER), the progesterone receptor (PR), and human epidermal growth factor receptor (HER)-2. Up to 80% of breast cancers are grouped as ER-positive, which implies a crucial role for estrogen in breast cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
